The importance of NK cells in murine models of cancer immunotherapy has been shown by multiple studies but is best illustrated by studies in which NK cell can fairly eradicate advanced tumors in the absence of CD8+ T cells, following activation with IL-15 [147]. The gene discussed is CD8A; the disease is cancer.